ADC Therapeutics (ADCT) Tax Provisions (2023 - 2025)

ADC Therapeutics' (ADCT) quarterly Tax Provisions came in at $1.3 million in Q2 2025, up 435.9% year-on-year from $234000.0 in Q2 2024, and up 660.0% quarter-over-quarter from $165000.0 in Q1 2025.

ADC Therapeutics (ADCT) Tax Provisions (2023 - 2025) Analysis & Trends

ADC Therapeutics has disclosed Tax Provisions across 3 years of filings, most recently posting $1.3 million for Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -11.20 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -859,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 216,000.00
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 221.50 Mn
9 Abivax 91.71 Bn 91.71 Bn - -
10 ADC Therapeutics 167.24 Mn -63.76 Mn 7.33 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 1.25 Mn
Mar 31, 2025 165,000.00
Sep 30, 2024 90,000.00
Jun 30, 2024 234,000.00
Mar 31, 2024 200,000.00
Sep 30, 2023 -85,000.00
Jun 30, 2023 -4.50 Mn